INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9475	Companies
185452	Keywords
117793	Articles
99303	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 1 month ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 year 1 month ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs
PRESS RELEASE

published on 10/14/2024 at 19:45, 1 year 1 month ago

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
Inventiva announces the availability of a prospectus for financing through the issuance of shares and warrants. The AMF approved the prospectus on October 14, 2024

Warrants Shares Financing Prospectus Inventiva
BRIEF

published on 08/30/2024 at 11:04, 1 year 3 months ago

UBS Group AG Crosses Threshold in INVENTIVA Capital

AMF Threshold Crossing Transfer Of Shares Inventiva UBS Group AG
BRIEF

published on 07/31/2024 at 22:05, 1 year 4 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information

Financial Results Revenue Inventiva H1 2024 R&D Expenses
PRESS RELEASE

published on 07/31/2024 at 22:00, 1 year 4 months ago

Inventiva Reports Preliminary 2024 First-Half Financial Information¹
Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones

Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
BRIEF

published on 07/25/2024 at 22:05, 1 year 4 months ago

Inventiva Secures Patent in Japan for Lanifibranor

Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
PRESS RELEASE

published on 07/25/2024 at 22:00, 1 year 4 months ago

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication

Patent Japan Inventiva Lanifibranor Cirrhosis
BRIEF

published on 07/23/2024 at 10:56, 1 year 4 months ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
BRIEF

published on 07/18/2024 at 08:35, 1 year 4 months ago

Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros

Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 40 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 45 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 15 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 10 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 15 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:00, 15 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 15 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 9 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 15 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 15 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 30 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 15 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 30 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE